Clipmarks
   
  
   
Matthew Herperfollowshare
6-30-2008 11:29 AM622 views
There were plenty of reasons to be skeptical, so this doesn't neccesarily dent the amyloid hypothesis. Still a disappointment. Myriad's diagnostic test business is cushioning the blow. Click on the article to read a nice take from Adam Feuerstein over at TheStreet.com.
Login to Comment.  Not a member yet? Sign up





Embed This Clip In Your Site...


OK